Case Studies Archive | George Clinical

George Clinical Guides Sponsor with Limited Clinical Trial Experience in Phase II Melanoma-TIL Trial

By George Clinical

Proactive identification of issues potentially affecting trial outcome led George Clinical to step in and provide services above and beyond original statement of work with full services, from protocol amendment to expanding manufacturing capabilities and easing patient waiting times. SITUATION George Clinical was contracted by a small biotechnology company for a Phase II, multi-center, […]

May 11th, 2020

George Clinical’s Full-Service Offerings Aid Acute Myelogenous Leukemia Study in Elderly Patients

By George Clinical

George Clinical takes over study management at start of Phase II as a rescue study. SITUATION When George Clinical was called upon to enter this Acute Myelogenous Leukemia Study in Elderly Patients at the start of Phase II, the client was dealing with a non-cooperative CRO, delays in site activation and low subject recruitment […]

May 7th, 2020

CREDENCE¹ Renal Outcomes Trial: India Operations Successfully Conducted

By George Clinical

George Clinical delivers India arm of this landmark trial with on-time recruitment and 100% retention. SITUATION “Nearly half of all people with type 2 diabetes will develop chronic kidney disease (CKD), causing a high risk of kidney failure and cardiovascular disease and impacting their quality and length of life, even with the current best […]

April 10th, 2020

Epidemiological Study of Hidradenitis Suppurativa (HS) in Australian Population

By George Clinical

One of the most rigorous and largest general population-based HS epidemiological studies reported thus far, for the first time sheds light on the prevalence and impact of HS in Australia as well as the demographic characteristics of the sufferers. SITUATION A large global pharmaceutical company was seeking a partner for a cross-sectional, observational, population-based […]

January 22nd, 2020

New Formulation ROTAVAC 5C Has the Lowest Cold Chain Footprint Amongst Oral Rotavirus Vaccine in the World

By George Clinical

Seamless coordination of complex pediatric Phase III clinical trial for ROTAVAC 5C® in India brings world closer to improving the global supply of affordable rotavirus vaccines. SITUATION George Clinical was selected by sponsor Bharat Biotech to conduct a seamless, sequential Phase III, randomized, multi-center, single-blind study to evaluate immunogenicity, safety and reactogenicity of liquid […]

November 13th, 2019

George Clinical leads China Component and Recruitment in World-First Large CPAP Device Trial

The Study Although Obstructive sleep apnea (OSA) is a very common condition that is associated with an increased risk of cardiovascular disease (CVD), there is much uncertainty over the effectiveness of treatment with nasal continuous positive airway pressure (CPAP) for the prevention of CVD. The SAVE trial was a multi-centre, open label, parallel, prospective, randomised, […]

June 20th, 2017

George Clinical Scientific Leaders boost recruitment for Phase 1 Patient Study

Utilizing key therapeutic knowledge leader networks as championed by George Clinical has again shown its effectiveness in boosting recruitment; this time for a Phase 1 renal patient trial. It is widely understood that the recruitment of patients into a Phase 1 trial can be fraught with difficulty. This difficulty arises from: A lack of established […]

January 23rd, 2017

Scientific Leadership: Our Communication Framework

Background George Clinical provides scientific leadership to clinical trials, where peer-to-peer engagement from clinicians is leveraged to facilitate study operations. In the traditional study operations model, clinical research associates (CRAs) typically engage with site personnel, such as study coordinators, on a day-to-day basis. Principal investigators, whose expertise and seniority at the site’s operational hierarchy, is […]

January 23rd, 2017

Renal Health: Recruitment Success in the Asia-Pacific

The Study George Clinical (GC) is collaborating with a global, research-based biopharmaceutical company to evaluate the effect of a new chemical entity in subjects with type 2 diabetes and nephropathy. George Clinical services GC is responsible for project management (PM) and monitoring throughout the Asia-Pacific. Other regions were managed by a separate contract research organization […]

January 23rd, 2017

Oncology: Recruitment Success in China

The Study George Clinical (GC) collaborated with a mid-sized global pharmaceutical company to conduct a randomized trial comparing pain relief medication for patients with moderate to severe chronic cancer pain. George Clinical services GC was responsible for project management (PM) and monitoring across 26 sites in China. Study sites were located in Beijing, Changchun, Dalian, […]

January 23rd, 2017